Additionally, progressive down-regulation of S100A16 as found in CRC, prostate and ovarian cancers (Additional file 3: Figure S2) demonstrates a broader relevance for S100A16 in the process of tumorigenesis of other human malignancies and warrants further investigation in these tumor types. Here, S100A16 is linked to ovarian cancer.